We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
(-2.6%)
Cap. Flow
-$4.15B
Cap. Flow
% of AUM
-9.34%
Top 10 Holdings %
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$309M |
| 2 |
ExxonMobil
XOM
|
+$302M |
| 3 |
Amazon
AMZN
|
+$291M |
| 4 |
Citigroup
C
|
+$253M |
| 5 |
Shopify
SHOP
|
+$238M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$383M |
| 2 |
Johnson & Johnson
JNJ
|
+$312M |
| 3 |
JPMorgan Chase
JPM
|
+$285M |
| 4 |
AT&T
T
|
+$191M |
| 5 |
Dollar General
DG
|
+$187M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.63% |
| 2 | Financials | 15.61% |
| 3 | Technology | 14.28% |
| 4 | Consumer Discretionary | 13.21% |
| 5 | Industrials | 5.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2701
TriplePoint Venture Growth BDC
TPVG
$184M
| $156K | ﹤0.01% |
15,000
-87,979
| -85% | -$1.06M |
|
2702
Smart Sand
SND
$179M
| $155K | ﹤0.01% |
+86,708
| New | +$164K |
|
2703
Kopin
KOPN
$586M
| $154K | ﹤0.01% |
123,803
-189,117
| -60% | -$234K |
|
|
CURO
2704
DELISTED
CURO Group Holdings Corp.
CURO
| $153K | ﹤0.01% |
+43,174
| New | +$165K |
|
|
GLDD
2705
DELISTED
Great Lakes Dredge & Dock
GLDD
| $153K | ﹤0.01% |
+25,737
| New | +$181K |
|
2706
ClearPoint Neuro
CLPT
$424M
| $153K | ﹤0.01% |
+18,046
| New | +$171K |
|
2707
inTEST
INTT
$143M
| $153K | ﹤0.01% |
14,817
-29,737
| -67% | -$276K |
|
2708
Annexon
ANNX
$796M
| $149K | ﹤0.01% |
+28,856
| New | +$159K |
|
2709
Costamare
CMRE
$1.85B
| $149K | ﹤0.01% |
16,067
-18,082
| -53% | -$170K |
|
2710
Similarweb
SMWB
$627M
| $149K | ﹤0.01% |
23,173
-89,956
| -80% | -$515K |
|
|
SCWX
2711
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
| $148K | ﹤0.01% |
+23,200
| New | +$164K |
|
2712
Latham Group
SWIM
$660M
| $147K | ﹤0.01% |
45,500
-48,700
| -52% | -$176K |
|
2713
Neuronetics
STIM
$127M
| $145K | ﹤0.01% |
+21,037
| New | +$99.3K |
|
2714
Gaotu Techedu
GOTU
$405M
| $144K | ﹤0.01% |
+61,121
| New | +$88.2K |
|
2715
Century Aluminum
CENX
$4.22B
| $143K | ﹤0.01% |
+17,490
| New | +$132K |
|
2716
Alta Equipment Group
ALTG
$194M
| $143K | ﹤0.01% |
10,831
-50,085
| -82% | -$603K |
|
2717
Compass Therapeutics
CMPX
$349M
| $142K | ﹤0.01% |
28,296
-23,520
| -45% | -$93.8K |
|
|
CRON
2718
Cronos Group
CRON
$1.07B
| $142K | ﹤0.01% |
+55,858
| New | +$164K |
|
|
SLVRW
2719
CALL
DELISTED
SilverSPAC Inc. Warrant
SLVRW
| $140K | ﹤0.01% |
13,996
| – | – |
|
|
NESR
2720
National Energy Services Reunited Corp
NESR
$2.46B
| $140K | ﹤0.01% |
20,138
-136,657
| -87% | -$904K |
|
2721
Chipotle Mexican Grill
CMG
$43.9B
| $139K | ﹤0.01% |
5,000
-125,950
| -96% | -$3.76M |
|
|
WKME
2722
DELISTED
WalkMe Ltd. Ordinary Shares
WKME
| $139K | ﹤0.01% |
12,400
-2,633
| -18% | -$23.1K |
|
2723
CALL
P3 Health Partners Inc Warrant
PIIIW
$126K
| $138K | ﹤0.01% |
75,000
-12,368
| -14% | -$6.44K |
|
|
NAGE
2724
Niagen Bioscience
NAGE
$256M
| $138K | ﹤0.01% |
82,092
| – | – |
|
2725
Immunic
IMUX
$178M
| $136K | ﹤0.01% |
9,749
+7,312
| +300% | +$199K |
|
Similar funds
Marshall Wace's Q4 2022 Portfolio in Review
As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.
Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.
- Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
- Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
- Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
- Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
- Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
- Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
- Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.
Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.